COMPANY
Sanofi Winthrop Industrie
Sanofi Winthrop Industrie: marketing authorisation holder for Lixisenatide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Lixisenatide | Lyxumia (EMEA/H/C/002445), Withdrawn Regulator EMA |
|---|---|
| Lixisenatide | Suliqua (EMEA/H/C/004243), Authorised Regulator EMA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.